Cargando…
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma
Recent studies have suggested that the interaction of mesothelin (MSLN) and cancer antigen 125 (CA125) enhances tumor metastases. The aim of the present study was to clarify the impact of MSLN and CA125 co-expression on the prognosis of patients with extrahepatic bile duct carcinoma (BDC). Tissue sa...
Autores principales: | Takihata, Yasuhiro, Einama, Takahiro, Kobayashi, Kazuki, Suzuki, Takafumi, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Yamagishi, Yoji, Iwasaki, Toshimitsu, Miyata, Yoichi, Shinto, Eiji, Ogata, Sho, Tsujimoto, Hironori, Ueno, Hideki, Kishi, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020376/ https://www.ncbi.nlm.nih.gov/pubmed/33841575 http://dx.doi.org/10.3892/ol.2021.12675 |
Ejemplares similares
-
Clinical Impact of Dual Time Point (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer
por: Einama, Takahiro, et al.
Publicado: (2022) -
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study
por: Kobayashi, Kazuki, et al.
Publicado: (2022) -
Prognosis of Pancreatic Cancer Based on Resectability: A Single Center Experience
por: Einama, Takahiro, et al.
Publicado: (2023) -
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
por: Einama, Takahiro, et al.
Publicado: (2021) -
Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report
por: Sota, Yuki, et al.
Publicado: (2021)